# Cryoport, Inc.: filings

CYRX · Nasdaq · CIK 1124524 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cyrx.md) · [Financials](/companies/cyrx/financials.md) · [Filings](/companies/cyrx/filings.md) · [Insiders](/companies/cyrx/insiders.md)

## Reports and events: 317 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 347, 8-K 188, 10-Q 53, CORRESP 38, 144 30, SC 13G/A 28, UPLOAD 24, 3 23, S-1/A 23, DEF 14A 18, 10-K 17, EFFECT 16, SC 13G 15, SCHEDULE 13G/A 14, S-8 13, D 11, 424B5 9, 4/A 9, SC TO-I/A 9, DEFA14A 8, POS AM 7, S-1 7, NT 10-Q 6, PRE 14A 6, SD 6, 8-K/A 5, 424B3 4, CT ORDER 4, D/A 4, S-4/A 4, 424B1 3, 5 3, S-3 3, SC TO-I 3, 10-K/A 2, 8-A12B 2, ARS 2, DEFR14A 2, PRER14A 2, S-4 2, SC 13D/A 2, 10-KT 1, 10-Q/A 1, 15-12G 1, 25-NSE 1, 3/A 1, 8-A12G 1, CERTNAS 1, FWP 1, NT 10-K 1, POSASR 1, S-3ASR 1, SC 13D 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 17:03 ET | [10-Q](/filings/0001104659-26-092107.md) | Quarterly report, period 2026-06-30 | 0001104659-26-092107 |
| 2026-08-06 | 16:30 ET | [8-K](/filings/0001104659-26-092064.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-092064 |
| 2026-06-09 | 17:00 ET | [8-K](/filings/0001104659-26-071892.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-071892 |
| 2026-05-05 | 14:36 ET | [10-Q](/filings/0001104659-26-055513.md) | Quarterly report, period 2026-03-31 | 0001104659-26-055513 |
| 2026-05-04 | 16:30 ET | [8-K](/filings/0001104659-26-054942.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-054942 |
| 2026-04-22 | 16:30 ET | [DEF 14A](/filings/0001140361-26-016129.md) | Proxy statement, period 2026-06-05 | 0001140361-26-016129 |
| 2026-03-05 | 16:53 ET | [10-K](/filings/0001104659-26-024180.md) | Annual report, period 2025-12-31 | 0001104659-26-024180 |
| 2026-03-03 | 17:10 ET | [8-K](/filings/0001104659-26-022940.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-022940 |
| 2025-11-06 | 14:33 ET | [10-Q](/filings/0001104659-25-107640.md) | Quarterly report, period 2025-09-30 | 0001104659-25-107640 |
| 2025-11-04 | 17:18 ET | [8-K](/filings/0001104659-25-106421.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-106421 |
| 2025-08-12 | 21:57 ET | [10-Q](/filings/0001558370-25-011127.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011127 |
| 2025-08-06 | 17:39 ET | [8-K](/filings/0001104659-25-074314.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-074314 |
| 2025-06-13 | 15:55 ET | [8-K](/filings/0001558370-25-008613.md) | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-25-008613 |
| 2025-06-10 | 09:00 ET | [8-K](/filings/0001104659-25-058019.md) | 5.07 Shareholder vote results | 0001104659-25-058019 |
| 2025-05-08 | 17:18 ET | [10-Q](/filings/0001558370-25-007012.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007012 |
| 2025-05-07 | 16:16 ET | [8-K](/filings/0001104659-25-045557.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-045557 |
| 2025-04-25 | 16:30 ET | [DEF 14A](/filings/0001140361-25-015777.md) | Proxy statement, period 2025-06-06 | 0001140361-25-015777 |
| 2025-03-31 | 08:17 ET | [8-K](/filings/0001104659-25-029642.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-029642 |
| 2025-03-07 | 17:02 ET | [10-K](/filings/0001558370-25-002509.md) | Annual report, period 2024-12-31 | 0001558370-25-002509 |
| 2025-03-04 | 17:07 ET | [8-K](/filings/0001104659-25-020404.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-020404 |
| 2024-11-07 | 16:56 ET | [10-Q](/filings/0001558370-24-014896.md) | Quarterly report, period 2024-09-30 | 0001558370-24-014896 |
| 2024-11-07 | 16:31 ET | [8-K](/filings/0001104659-24-115344.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-115344 |
| 2024-08-08 | 14:55 ET | [10-Q](/filings/0001558370-24-011562.md) | Quarterly report, period 2024-06-30 | 0001558370-24-011562 |
| 2024-08-06 | 17:17 ET | [8-K](/filings/0001104659-24-086344.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-086344 |
| 2024-08-06 | 16:34 ET | [8-K](/filings/0001104659-24-086305.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-086305 |
| 2024-05-22 | 17:10 ET | [8-K](/filings/0001104659-24-064333.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-064333 |
| 2024-05-08 | 19:03 ET | [10-Q](/filings/0001558370-24-007133.md) | Quarterly report, period 2024-03-31 | 0001558370-24-007133 |
| 2024-05-07 | 16:53 ET | [8-K](/filings/0001104659-24-058082.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-058082 |
| 2024-04-03 | 16:18 ET | [DEF 14A](/filings/0001140361-24-017597.md) | Proxy statement, period 2024-05-17 | 0001140361-24-017597 |
| 2024-03-13 | 17:26 ET | [10-K](/filings/0001558370-24-003128.md) | Annual report, period 2023-12-31 | 0001558370-24-003128 |
| 2024-03-12 | 16:30 ET | [8-K](/filings/0001104659-24-033491.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-033491 |
| 2024-02-15 | 16:42 ET | [8-K](/filings/0001104659-24-024562.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-024562 |
| 2023-11-15 | 16:30 ET | [8-K](/filings/0001104659-23-118697.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001104659-23-118697 |
| 2023-11-09 | 14:18 ET | [10-Q](/filings/0001558370-23-018511.md) | Quarterly report, period 2023-09-30 | 0001558370-23-018511 |
| 2023-11-08 | 16:31 ET | [8-K](/filings/0001104659-23-115766.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-115766 |
| 2023-08-09 | 17:28 ET | [8-K](/filings/0001104659-23-089376.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-089376 |
| 2023-08-09 | 16:47 ET | [10-Q](/filings/0001410578-23-001635.md) | Quarterly report, period 2023-06-30 | 0001410578-23-001635 |
| 2023-07-12 | 16:31 ET | [8-K](/filings/0001104659-23-080348.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-080348 |
| 2023-05-16 | 17:29 ET | [8-K](/filings/0001104659-23-061489.md) | 5.07 Shareholder vote results | 0001104659-23-061489 |
| 2023-05-04 | 17:22 ET | [10-Q](/filings/0001410578-23-000882.md) | Quarterly report, period 2023-03-31 | 0001410578-23-000882 |
| 2023-05-04 | 16:32 ET | [8-K](/filings/0001104659-23-056041.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-056041 |
| 2023-03-31 | 16:36 ET | [DEF 14A](/filings/0001140361-23-015386.md) | Proxy statement | 0001140361-23-015386 |
| 2023-03-28 | 17:15 ET | [8-K](/filings/0001104659-23-037784.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-037784 |
| 2023-03-15 | 16:31 ET | [8-K](/filings/0001104659-23-032821.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001104659-23-032821 |
| 2023-02-28 | 17:08 ET | [10-K](/filings/0001410578-23-000188.md) | Annual report, period 2022-12-31 | 0001410578-23-000188 |
| 2023-02-23 | 16:47 ET | [8-K](/filings/0001104659-23-024795.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-23-024795 |
| 2022-11-04 | 15:14 ET | [10-Q](/filings/0001410578-22-002947.md) | Quarterly report, period 2022-09-30 | 0001410578-22-002947 |
| 2022-11-03 | 16:30 ET | [8-K](/filings/0001104659-22-114437.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-114437 |
| 2022-08-04 | 17:04 ET | [10-Q](/filings/0001410578-22-002045.md) | Quarterly report, period 2022-06-30 | 0001410578-22-002045 |
| 2022-08-04 | 16:31 ET | [8-K](/filings/0001104659-22-086174.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-086174 |

Page 1 of 7. [Older](/companies/cyrx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.